Aptamers News and Research

RSS
Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

New approach to biomarker detection for early lung cancer diagnosis

New approach to biomarker detection for early lung cancer diagnosis

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Regado presents poster on REG3 at AHA Scientific Sessions meeting

Regado presents poster on REG3 at AHA Scientific Sessions meeting

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Dicerna secures $4 million in second closing of Series B equity financing

Dicerna secures $4 million in second closing of Series B equity financing

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

NEC, SomaLogic sign agreement to explore aptamer related businesses in life sciences, healthcare markets

NEC, SomaLogic sign agreement to explore aptamer related businesses in life sciences, healthcare markets

Dicerna announces closing of $25 million Series B round of financing

Dicerna announces closing of $25 million Series B round of financing

Texas Tech signs worldwide license agreement for metallo-beta-lactamase inhibitors with RI Scientific

Texas Tech signs worldwide license agreement for metallo-beta-lactamase inhibitors with RI Scientific

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

NOXXON Pharma completes first-in-human clinical trial with Spiegelmer NOX-A12

NOXXON Pharma completes first-in-human clinical trial with Spiegelmer NOX-A12

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Regado Biosciences announces first successful subcutaneous application of an aptamer

Regado Biosciences announces first successful subcutaneous application of an aptamer

New strategy against Botulinum toxin

New strategy against Botulinum toxin

Regado Biosciences announces completion of Series D financing

Regado Biosciences announces completion of Series D financing

Albert Einstein College of Medicine receives SU2C grant for cancer research

Albert Einstein College of Medicine receives SU2C grant for cancer research

NOXXON Pharma achieves important milestone in drug discovery

NOXXON Pharma achieves important milestone in drug discovery

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Researchers devise a way to deliver right therapy directly to tumors using aptamers